Abstract:Background: Alcohol relapse is a major problem in the treatment of alcohol abuse and alcoholism. Understanding the long-term neuronal alterations that promote relapse of alcohol drinking is critical for the development of pharmacotherapies to treat alcoholism and alcohol abuse. The major objectives of this workshop were to present recent findings, by using rodent models, on behavioral and neurobiological factors that may underlie alcohol relapse and the results of clinical and pharmacological treatment strategies for preventing relapse. Methods: Prolonged ethanol drinking and repeated periods of alcohol deprivation were studied in nonselected rats and in rats selectively bred for high alcohol preference (P rat). The expression of a robust alcohol deprivation effect (ADE) was used as a model for alcohol relapse in rodents. Operant techniques were used to examine responding for ethanol after deprivation in both rats and C57BL/6J mice. Environmental cues and stress were used to assess their effects on reinstatement of alcohol responding. Microdialysis and [14C]-2-deoxyglucose techniques were used to examine neuronal alterations associated with alcohol relapse. Results: Prolonged free-choice ethanol drinking followed by deprivation produced an ADE in both stock and P rats. These rats demonstrated loss of control on reinstatement after chronic drinking and after prolonged deprivation. Acamprosate and naltrexone effectively reduced the ADE in stock rats. Stress reinstated operant responding for alcohol, and rats trained to associate a cue with ethanol presentation increased responding on the ethanol-associated lever in the absence of ethanol. After repeated deprivations, P rats shifted their preference toward drinking higher concentrations of ethanol, which increased the magnitude and duration of the ADE. Stock rats also shifted their preference toward solutions with higher ethanol concentrations and demonstrated a loss of control after prolonged ethanol drinking and deprivation. Long-lasting alterations in neuronal activity, serotonin-3 receptor function, and dopamine neurotransmission within the mesolimbic system were evident after chronic drinking that followed a prolonged deprivation period. Conclusions: The ADE is a useful model for studying alcohol relapse in both rats and mice. The potential validity of this model is supported by the findings that acamprosate and naltrexone are effective in preventing the ADE in rodents, and both compounds have gained recognition for their therapeutic effects in clinical populations. Genetics, stress, and environmental cues are all important factors that influence alcohol relapse. Long-term alterations in neuronal activity within the mesolimbic system, which possibly involve dopamine and serotonin, may underlie alcohol relapse.

Environmental enrichment and complementary clinical interventions as therapeutic approaches for alcohol use disorder in animal models and humans

Animal models for studying therapeutic targets and treatments for alcohol use disorder

A Systematic Review and Meta-analysis on the Transcriptomic Signatures in Alcohol Use Disorder

Introduction: Approved treatments for alcohol use disorder by regulatory agencies

Animal models of compulsion alcohol drinking: Why we love quinine-resistant intake and what we learned from it

Therapeutic Interventions of Gut-Brain Axis as Novel Strategies for Treatment of Alcohol Use Disorder Associated Cognitive and Mood Dysfunction

Sex differences in basal motivated behavior, chronic ethanol drinking, and amygdala activity in female and male mice

Emerging pharmacological targets for alcohol use disorder

Treatment of Alcohol Use Disorder: Behavioral and Pharmacologic Therapies

Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies

[Epigenetic changes in alcohol addiction and therapeutic perspectives]

Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder

The role of brain serotonin signaling in excessive alcohol consumption and withdrawal: A call for more research in females

The Behavioral Economics and Neuroeconomics of Alcohol Use Disorders

Neuromodulation and mindfulness as therapeutic treatment in detoxified patients with alcohol use disorder

Central nervous system mechanisms in alcohol relapse

Unlocking the role of dorsal hippocampal α4β2 nicotinic acetylcholine receptors in Ethanol-Induced conditioned place preference in mice

Targeting Persistent Changes in Neuroimmune and Epigenetic Signaling in Adolescent Drinking to Treat Alcohol Use Disorder in Adulthood

β-arrestin-biased Allosteric Modulator of Neurotensin Receptor 1 Reduces Ethanol Drinking and Responses to Ethanol Administration in Rodents

Role of oxytocin and vasopressin in alcohol use disorder

Ethanol drinking sex-dependently alters cortical IL-1β synaptic signaling and cognitive behavior in mice